iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt

被引:0
|
作者
Tesar, Paul
Elitt, Matthew
机构
来源
STEM CELL REPORTS | 2018年 / 11卷 / 03期
关键词
D O I
10.1016/j.stemcr.2018.08.020
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This month we present a new Q&A with Paul Tesar, DPhil, Associate Professor and Director of the Pluripotent Stem Cell Facility at Case Western Reserve University (U.S.). Dr. Tesar is a recipient of the Beddington Medal of the British Society for Developmental Biology and the 2015 recipient of the ISSCR's Young Investigator Award. Stem Cell Reports has invited Dr. Tesar and graduate student Matthew Elitt, the first author of Elitt et al. (in this issue of Stem Cell Reports), to answer some questions about their publication and share perspective and insights on their research and mentoring the next generation of scientists.
引用
收藏
页码:613 / 615
页数:3
相关论文
共 50 条
  • [31] Modeling Neurodevelopmental Disorder Using Human iPSC-Based Microglial Mouse Chimeras
    Jiang, P.
    GLIA, 2021, 69 : E72 - E72
  • [32] iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease
    Kondo, Takayuki
    Imamura, Keiko
    Funayama, Misato
    Tsukita, Kayoko
    Miyake, Michiyo
    Ohta, Akira
    Woltjen, Knut
    Nakagawa, Masato
    Asada, Takashi
    Arai, Tetsuaki
    Kawakatsu, Shinobu
    Izumi, Yuishin
    Kaji, Ryuji
    Iwata, Nobuhisa
    Inoue, Haruhisa
    CELL REPORTS, 2017, 21 (08): : 2304 - 2312
  • [33] Integration of Nonlinear Analysis and Artificial Intelligence for Human Ipsc-based Drug Cardiotoxicity Classification
    Ma, Zhen
    Kowalczewski, Andrew
    CIRCULATION, 2021, 144
  • [34] Your Heart on a Chip: iPSC-Based Modeling of Barth-Syndrome-Associated Cardiomyopathy
    Zweigerdt, Robert
    Gruh, Ina
    Martin, Ulrich
    CELL STEM CELL, 2014, 15 (01) : 10 - 12
  • [35] Bridging the Translational Gap in Chemotherapy-Induced Peripheral Neuropathy with iPSC-Based Modeling
    Mortensen, Christina
    Andersen, Nanna Elman
    Stage, Tore Bjerregaard
    CANCERS, 2022, 14 (16)
  • [36] Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening
    Smith, Alec S. T.
    Macadangdang, Jesse
    Leung, Winnie
    Laflamme, Michael A.
    Kim, Deok-Ho
    BIOTECHNOLOGY ADVANCES, 2017, 35 (01) : 77 - 94
  • [37] Genetic Correction of Phospholamban Mutation in an iPSC-Based Disease Model of Familial Dilated Cardiomyopathy
    Nonnenmacher, Mathieu E.
    Karakikes, Ioannis
    Stillitano, Francesca
    Weber, Thomas
    Hajjar, Roger J.
    MOLECULAR THERAPY, 2014, 22 : S193 - S193
  • [38] Human iPSC modeling of heart disease for drug development
    Hnatiuk, Anna P.
    Briganti, Francesca
    Staudt, David W.
    Mercola, Mark
    CELL CHEMICAL BIOLOGY, 2021, 28 (03) : 271 - 282
  • [39] Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling
    Germain, Pierre-Luc
    Testa, Giuseppe
    STEM CELL REPORTS, 2017, 8 (06): : 1784 - 1796
  • [40] A HUMAN IPSC-BASED 3D MICROPHYSIOLOGICAL SYSTEM FOR MODELING CARDIAC DYSFUNCTION IN MICROGRAVITY
    Mair, Devin B.
    Tsui, Jonathan H.
    Higashi, Ty
    Williams, Marcus A. C.
    Ahn, Eun Hyun
    Lee, Peter H. U.
    Countryman, Stefanie
    Sniadecki, Nathan J.
    Kim, Deok-Ho
    TISSUE ENGINEERING PART A, 2022, 28 : S625 - S625